MX2018006283A - Composiciones bacterianas diseñadas. - Google Patents

Composiciones bacterianas diseñadas.

Info

Publication number
MX2018006283A
MX2018006283A MX2018006283A MX2018006283A MX2018006283A MX 2018006283 A MX2018006283 A MX 2018006283A MX 2018006283 A MX2018006283 A MX 2018006283A MX 2018006283 A MX2018006283 A MX 2018006283A MX 2018006283 A MX2018006283 A MX 2018006283A
Authority
MX
Mexico
Prior art keywords
bacterial compositions
designed bacterial
designed
compositions
treating
Prior art date
Application number
MX2018006283A
Other languages
English (en)
Inventor
Cook David
HENN Matthew
Button Julie
Litcofsky Kevin
Martinez Asuncion
Mckenzie Gregory
Nandakumar Madhumitha
Vulic Marin
Wortman Jennifer
Jane Lombardo Mckenzie Mary-
Original Assignee
Seres Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seres Therapeutics Inc filed Critical Seres Therapeutics Inc
Publication of MX2018006283A publication Critical patent/MX2018006283A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)

Abstract

Se proporcionan composiciones y métodos para tratar disbiosis gastrointestinal mediante el uso de una cantidad limitada de especies bacterianas definidas.
MX2018006283A 2015-11-24 2016-11-23 Composiciones bacterianas diseñadas. MX2018006283A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201562259523P 2015-11-24 2015-11-24
US201662351696P 2016-06-17 2016-06-17
US201662401011P 2016-09-28 2016-09-28
PCT/US2016/063697 WO2017091783A2 (en) 2015-11-24 2016-11-23 Designed bacterial compositions

Publications (1)

Publication Number Publication Date
MX2018006283A true MX2018006283A (es) 2019-09-06

Family

ID=57614452

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2018006283A MX2018006283A (es) 2015-11-24 2016-11-23 Composiciones bacterianas diseñadas.

Country Status (15)

Country Link
US (2) US20190247447A1 (es)
EP (2) EP4233884A3 (es)
JP (2) JP7523884B2 (es)
KR (1) KR20180083894A (es)
CN (1) CN109661236A (es)
AU (2) AU2016359178A1 (es)
BR (1) BR112018010430A2 (es)
CA (1) CA3006187A1 (es)
DK (1) DK3380108T3 (es)
ES (1) ES2938361T3 (es)
FI (1) FI3380108T3 (es)
MX (1) MX2018006283A (es)
PL (1) PL3380108T3 (es)
PT (1) PT3380108T (es)
WO (1) WO2017091783A2 (es)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
KR102617655B1 (ko) 2012-11-23 2023-12-27 세레스 테라퓨틱스, 인코포레이티드 상승작용적 박테리아 조성물, 그리고 이의 제조 방법 및 용도
EP2951283A4 (en) 2013-02-04 2017-01-25 Seres Therapeutics, Inc. Compositions and methods
KR20230110367A (ko) 2013-02-04 2023-07-21 세레스 테라퓨틱스, 인코포레이티드 조성물 및 방법
EP2967077A4 (en) 2013-03-15 2016-09-14 Seres Therapeutics Inc MICROBIAL COMPOSITIONS AND ASSOCIATED METHODS BASED ON A NETWORK
US10258655B2 (en) 2013-11-25 2019-04-16 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
EP3881680A1 (en) 2014-10-31 2021-09-22 Pendulum Therapeutics, Inc. Methods and compositions relating to microbial treatment
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
US9999641B2 (en) 2016-06-14 2018-06-19 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
US11959125B2 (en) * 2016-09-15 2024-04-16 Sun Genomics, Inc. Universal method for extracting nucleic acid molecules from a diverse population of one or more types of microbes in a sample
EP3606325B1 (en) 2017-04-03 2024-09-04 Gusto Global, LLC Rational design of microbial-based biotherapeutics
HUE052258T2 (hu) 2017-06-14 2021-04-28 4D Pharma Res Ltd Megasphaera nemzetségbe tartozó baktériumtörzset tartalmazó készítmény, és alkalmazása
WO2018237316A1 (en) * 2017-06-22 2018-12-27 President And Fellows Of Harvard College INHIBITION OF INNATED GROUP 3 LYMPHOID CELLS FROM THE COLON
CA3072032A1 (en) * 2017-08-07 2019-02-14 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
KR102680943B1 (ko) 2017-08-14 2024-07-03 세레스 테라퓨틱스, 인코포레이티드 담즙정체성 질환 치료를 위한 조성물 및 방법
CA3073838A1 (en) 2017-08-30 2019-03-07 Pendulum Therapeutics, Inc. Methods and compositions for treatment of microbiome-associated disorders
AU2018346255A1 (en) * 2017-10-03 2020-04-23 Seres Therapeutics, Inc. Manipulation of tryptamine metabolism
MX2020004495A (es) * 2017-10-30 2021-01-08 Seres Therapeutics Inc Composiciones y métodos para tratar la resistencia a los antibióticos.
WO2019169143A1 (en) * 2018-02-28 2019-09-06 Evelo Biosciences, Inc. Compositions and methods for treating cancer using turicibacter sanguinis
AU2019245430A1 (en) * 2018-03-29 2020-10-22 Seres Therapeutics, Inc. Compositions and methods for treating inflammatory bowel diseases
WO2019200271A1 (en) 2018-04-13 2019-10-17 White Dog Labs, Inc. An improved method for selecting probiotics
CN112601534A (zh) * 2018-05-11 2021-04-02 4D制药研究有限公司 包含细菌菌株的组合物
CA3101184A1 (en) * 2018-05-24 2019-11-28 Seres Therapeutics, Inc. Designed bacterial compositions and uses thereof
EP3922256A1 (en) * 2018-06-25 2021-12-15 4D Pharma Research Limited Compositions comprising bacterial strains
KR20200021257A (ko) 2018-08-20 2020-02-28 아주대학교산학협력단 유박테리움 렉탈레를 포함하는 베체트병 또는 헤르페스 바이러스 감염증의 예방 또는 치료용 조성물
JP7451185B2 (ja) * 2019-01-22 2024-03-18 株式会社ダイセル 新規微生物およびその利用
US20220213493A1 (en) * 2019-05-07 2022-07-07 North Carolina State University Compositions and methods for modulating the gastrointestinal tract using bile salt hydrolases
KR102379022B1 (ko) * 2019-05-24 2022-03-28 주식회사 엠디헬스케어 qPCR 분석을 통한 위암 진단방법
CN112481395B (zh) * 2019-09-12 2024-10-18 深圳华大生命科学研究院 艰难梭菌耐药/低敏感进化分支snp标记及菌株类别鉴定方法和应用
WO2021108728A1 (en) * 2019-11-27 2021-06-03 Seres Therapeutics, Inc. Designed bacterial compositions and uses thereof
EP3838281A1 (en) * 2019-12-20 2021-06-23 4D Pharma Research Limited Compositions comprising bacterial strains
US20240139222A1 (en) 2020-08-14 2024-05-02 Prolacta Bioscience, Inc. Human milk oligosaccharide compositions for use with bacteriotherapies

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102617655B1 (ko) * 2012-11-23 2023-12-27 세레스 테라퓨틱스, 인코포레이티드 상승작용적 박테리아 조성물, 그리고 이의 제조 방법 및 용도
US8906668B2 (en) * 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
KR20230110367A (ko) * 2013-02-04 2023-07-21 세레스 테라퓨틱스, 인코포레이티드 조성물 및 방법
EP2951283A4 (en) * 2013-02-04 2017-01-25 Seres Therapeutics, Inc. Compositions and methods
US10258655B2 (en) * 2013-11-25 2019-04-16 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
WO2015095241A2 (en) * 2013-12-16 2015-06-25 Seres Health, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders

Also Published As

Publication number Publication date
EP3380108A2 (en) 2018-10-03
CA3006187A1 (en) 2017-06-01
RU2018122664A (ru) 2019-12-25
RU2018122664A3 (es) 2020-04-15
PL3380108T3 (pl) 2023-03-27
EP3380108B1 (en) 2022-11-16
BR112018010430A2 (pt) 2018-11-27
JP2022033885A (ja) 2022-03-02
WO2017091783A3 (en) 2017-07-13
ES2938361T3 (es) 2023-04-10
PT3380108T (pt) 2023-02-17
KR20180083894A (ko) 2018-07-23
AU2024200663A1 (en) 2024-02-22
FI3380108T3 (fi) 2023-03-03
EP4233884A2 (en) 2023-08-30
JP7523884B2 (ja) 2024-07-29
AU2016359178A1 (en) 2018-06-14
EP4233884A3 (en) 2023-10-04
WO2017091783A2 (en) 2017-06-01
US20240216444A1 (en) 2024-07-04
US20190247447A1 (en) 2019-08-15
CN109661236A (zh) 2019-04-19
DK3380108T3 (da) 2023-02-06
JP2019501136A (ja) 2019-01-17

Similar Documents

Publication Publication Date Title
MX2018006283A (es) Composiciones bacterianas diseñadas.
MX2021000710A (es) Composiciones que comprenden cepas bacterianas.
HK1243640A1 (zh) 用於治療潰瘍的方法和組合物
IL262258A (en) A new bacterial species
TW201613966A (en) SynTac polypeptides and uses thereof
MX2017016529A (es) Composiciones que comprenden cepas bacterianas.
MX2017016398A (es) Composiciones que comprenden cepas bacterianas.
MX2017016525A (es) Composiciones que comprenden cepas bacterianas.
WO2015117081A3 (en) Methods and compositions for treatment of a beta thalessemia
HK1249432A1 (zh) 治療細菌感染的方法
EP3408344A4 (en) METHOD AND COMPOSITIONS FOR BORING TREATMENT
EP3209298A4 (en) Compositions and methods for treating insomnia
GB2553919B (en) Biomass treatment apparatus
EP3268010A4 (en) Compositions and methods for treating bacterial infection
MX2018000291A (es) Metodos para tratar la colitis.
PH12017501864A1 (en) Compositions and methods for treating autism
IL291266A (en) Preparations and methods for treating infections
MX2016009537A (es) Metodo para tratar ropa.
HK1221604A1 (zh) 豬苓菌與蜜環菌屬的種的共生方法及使用該方法的豬苓菌的栽培方法
EP3190893A4 (en) Compositions and methods for treating and preventing bacterial infections
HK1254232A1 (zh) 用於治療胃潰瘍的方法和組合物
MY167350A (en) Fat-and-oil composition and chocolate
EP3139744A4 (en) Methods and compositions for treating and preventing tinnitus
ZA201606811B (en) Compositions and methods for identifying ehrlichia species
MX2016009541A (es) Metodo para tratar vajilla.